Antibody-drug Conjugates Market Share

Market Share of Antibody-drug Conjugates Industry

The antibody-drug conjugates market is slightly fragmented in nature and competitive due to the presence of several companies across the globe. The competitive landscape includes an analysis of a few international and local companies that hold major market shares, including Seagen Inc., ImmunoGen Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., AstraZeneca PLC, Gilead Sciences Inc, and others.

Antibody Drug Conjugates Market Leaders

1. Seagen Inc.

2. F Hoffmann-La Roche Ltd

3. Pfizer Inc

4. AstraZeneca

5. Gilead Sciences, Inc

*Disclaimer: Major Players sorted in no particular order